Last Updated: September 28, 2026

LOREEV XR Drug Patent Profile

✉ Email this page to a colleague

« Back to Dashboard

Which patents cover Loreev Xr, and when can generic versions of Loreev Xr launch?

Loreev Xr is a drug marketed by Almatica and is included in one NDA. There is one patent protecting this drug.

The generic ingredient in LOREEV XR is lorazepam. Thirty-nine suppliers are listed for this compound. Additional details are available on the lorazepam profile page.

DrugPatentWatch^® Litigation and Generic Entry Outlook for Loreev Xr

A generic version of LOREEV XR was approved as lorazepam by SANDOZ on April 21^st, 1987.

Start Trial

AI Deep Research

Questions you can ask:

What is the 5 year forecast for LOREEV XR?
What are the global sales for LOREEV XR?
What is Average Wholesale Price for LOREEV XR?

Summary for LOREEV XR

US Patents:	1
Applicants:	1
NDAs:	1

US Patents and Regulatory Information for LOREEV XR

LOREEV XR is protected by one US patents.

+ Get email alerts for changes to this table

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Almatica	LOREEV XR	lorazepam	CAPSULE, EXTENDED RELEASE;ORAL	214826-001	Aug 27, 2021		RX	Yes	No	⤷ Start Trial	⤷ Start Trial	Y			⤷ Start Trial
Almatica	LOREEV XR	lorazepam	CAPSULE, EXTENDED RELEASE;ORAL	214826-003	Aug 27, 2021		RX	Yes	Yes	⤷ Start Trial	⤷ Start Trial	Y			⤷ Start Trial
Almatica	LOREEV XR	lorazepam	CAPSULE, EXTENDED RELEASE;ORAL	214826-004	Feb 16, 2022		RX	Yes	No	⤷ Start Trial	⤷ Start Trial	Y			⤷ Start Trial
Almatica	LOREEV XR	lorazepam	CAPSULE, EXTENDED RELEASE;ORAL	214826-002	Aug 27, 2021		RX	Yes	No	⤷ Start Trial	⤷ Start Trial	Y			⤷ Start Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

International Patents for LOREEV XR

See the table below for patents covering LOREEV XR around the world.

Subscribe to access the full database, or Start Trial
Country	Patent Number	Title	Estimated Expiration
Argentina	094391		⤷ Start Trial
Australia	2014205440		⤷ Start Trial
Brazil	112015016304		⤷ Start Trial
Canada	2897302		⤷ Start Trial
Chile	2015001920		⤷ Start Trial
>Country	>Patent Number	>Title	>Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.